Cosmetic industry

1,000 Dreams Fund's All-Women's BroadcastHER Esports Tournament Returns in Partnership with Paidia Gaming, Girls Gotta Game, and e.l.f. Cosmetics

Retrieved on: 
Friday, January 20, 2023
Esports, Female, Respawn Entertainment, Partnership, Football at the 2020 Summer Olympics – Women's tournament – Final, HP Inc., Women's History Month, Hero, Dream, Apex Legends, E.l.f. (cosmetics), Cosmetic industry, Initiative, Cosmetics, Video game, Woman, Paidia, Legend (disambiguation)

WASHINGTON, Jan. 20, 2023 /PRNewswire/ -- 1,000 Dreams Fund (1DF), a national nonprofit that supports the dreams of talented young women in need, announces today the return of its all-women's BroadcastHER Esports Tournament for a second year, streaming exclusively on Twitch.

Key Points: 
  • The BroadcastHER Tournament returns in partnership with Paidia Gaming and Girls Gotta Game , and supported by e.l.f.
  • The BroadcastHER Tournament includes more than $10,000 in prizing up for grabs — thanks to tournament sponsors e.l.f.
  • Thanks to the support of Paidia Gaming and Girls Gotta Game, along with our title sponsor, e.l.f.
  • Their BroadcastHER Tournament, in collaboration with Paidia Gaming and Girls Gotta Game, is just one more way they're doing just that.

EQS-News: Symrise AG expands its Executive Board

Retrieved on: 
Thursday, February 2, 2023
Lanxess, Drink, Human resources, CFO, Foodservice, Head, Taste, News, Food, RTÉ Executive Board, Supervisory board, Odor, Cosmetic industry, Cosmetics, Pet food, Life, Security (finance), Management, Medicine, Perfume, Symrise

—           New distribution of responsibilities for Executive Board starting February 1, 2023

Key Points: 
  • —           New distribution of responsibilities for Executive Board starting February 1, 2023
    Symrise AG is expanding its Executive Board and has hired the experienced manager Dr. Stephanie Cossmann to take over the newly created executive responsibilities for the Human Resources and Legal group.
  • Cossmann (49), who has a doctorate in law, most recently was a member of the Executive Board and Head of HR at Lanxess AG.
  • Michael König, Chairman of the Supervisory Board of Symrise AG, comments: “By expanding the Executive Board, we are sending an important signal for the further growth course of Symrise.
  • Symrise – always inspiring more …
    31.01.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

EQS-News: Symrise AG: Following a strong third quarter, Symrise again raises forecast for the year as a whole

Retrieved on: 
Friday, October 28, 2022
Cosmetics, Food, EBITDA, Aladdin (food & beverage containers), Leisure, Symrise, Pet food, Life, CAGR, Growth, Drink, Sensient Technologies, Color, Nutrition, Taste, Hygiene, Household, Natural, Nutrition and Health, News, Cosmetic industry, Oral hygiene, Video game, Fine chemical, Bottled water, Perfume, Group, Dimethyl dicarbonate, Aroma compound

Symrise AG: Following a strong third quarter, Symrise again raises forecast for the year as a whole (news with additional features)

Key Points: 
  • Symrise AG: Following a strong third quarter, Symrise again raises forecast for the year as a whole (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • Following a strong third quarter, Symrise again raises forecast for the year as a whole
    Following a strong third quarter, Symrise AG is again raising its forecast for 2022 as a whole.
  • The Fine Fragrances business unit continued to develop dynamically, once again achieving high organic growth following a strong previous year.
  • About Symrise: Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients.

Efficacy Testing Global Industry Report 2022: Growing Preference for Outsourcing Efficacy Testing to Drive Market Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 18, 2022
Science, Health, Other Science, Other Health, Adoption, Time, Use, Government, Growth, Laboratory, Final good, CAGR, Cosmetics, Cosmetic industry, Region, Awareness, Incidence, Conditional sentence, ADC, Medical device, Microbiology, USD, Contamination control, Personal care, Pharmaceutical industry, Pharma, Arbutus Biopharma

The "Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharma, Cosmetics & Personal Care, Medical Devices, Consumer Products) and Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharma, Cosmetics & Personal Care, Medical Devices, Consumer Products) and Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global efficacy testing market is projected to reach USD 423 million by 2027 from USD 315 million in 2022, at a CAGR of 6.1% during the forecast period.
  • The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach.
  • The high growth potential in emerging markets will provide growth opportunities for players operating in the efficacy testing market.

Real Brands Signs Definitive Agreement for the Acquisition of Boulder Botanical & Biosciences Laboratories Assets

Retrieved on: 
Tuesday, September 27, 2022
GE, Target, Safety, Compliance, Industry, Good manufacturing practice, CASH, Tablet, Club, COVID-19, Compound annual growth rate, Company, Acquisition, Herbal, SMB, IP, TPB, Cannabidiol, 7-Eleven, Cosmetic industry, CAGR, CO, Providence, NYSE, RI, Real, Sports medicine, OTCQB, Joint Medical Service (Germany), CEO, Safeway, CVS, Circle K, GLOBE, GMP, Health, Whole Foods Market, LLC, Gel, Edible, General Electric, Risk, Simulated moving bed, Botany, Dietary supplement, Risk management, CBD, Costco

North Providence, RI, and Golden, CO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCQB: RLBD) announced today that it has signed the definitive agreement for the acquisition of substantially all the assets of Boulder Botanical & Biosciences Laboratories, Inc. ( Boulder Botanical ), a manufacturer of white-label and private-label wellness and sports medicine herbal supplements and CBD products, from Frankens Investment Fund, LLC, which had acquired Boulder Botanical in April 2022.

Key Points: 
  • North Providence, RI, and Golden, CO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc. (OTCQB: RLBD) announced today that it has signed the definitive agreement for the acquisition of substantially all the assets of Boulder Botanical & Biosciences Laboratories, Inc. ( Boulder Botanical ), a manufacturer of white-label and private-label wellness and sports medicine herbal supplements and CBD products, from Frankens Investment Fund, LLC, which had acquired Boulder Botanical in April 2022.
  • The acquisition will include Boulder Botanicals brands for human and pet markets, IP, and distribution at the 27,000 sq.
  • Boulder Botanical will retain its name and operate as a division of Real Brands.
  • Thom Kidrin, President & CEO of Real Brands Inc., stated, Boulder Botanical has had an excellent reputation for creating quality sports medicine, health and wellness herbal supplements and cannabinoid formulations and its white-label manufacturing services exceeding industry standards.

DGAP-News: Symrise achieves strong sales growth in the first half of 2022

Retrieved on: 
Tuesday, August 2, 2022
Pet food, Group, Food, Cosmetics, Nutrition and Health, Awareness, Natural, EBIT, Sale, Leisure, Â, Protein, Egg, Acquisition, Menthol cigarette, Travel, Drink, CAGR, Solution, Oral hygiene, Household, Taste, Dimethyl dicarbonate, Sensient Technologies, Coronavirus, Life, Nutrition, Color, Tax, Cosmetic industry, Growth, Depreciation, Hygiene, EBITDA, Fine chemical, Animal, Bookkeeping, Perfume, Airline, Online gambling, EU, Aroma compound, Symrise, Giraffe

Symrise AG continues its growth course in the first half of 2022.

Key Points: 
  • Symrise AG continues its growth course in the first half of 2022.
  • The Symrise Group achieved sales growth of 18.5 % in the first half of 2022.
  • Taste, Nutrition & Health achieved organic sales growth of 12.7 % in the first half of 2022.
  • The recent acquisitions also contributed to the growth of the business unit, resulting in significant overall double-digit percentage sales growth.

Real Brands Signs Letter of Intent to Acquire Assets of Boulder Botanical

Retrieved on: 
Thursday, June 2, 2022
7-Eleven, Powder, Whole Foods Market, Company, OTCQB, Circle K, Research, Simulated moving bed, LLC, IP, R, Real, D, Joint Medical Service (Germany), Golden, Colorado, RI, Letter, CEO, GMP, Boulder, Gel, CASH, GLOBE, Club, Media relations, Target, Acquisition, COVID-19, Tablet, Compliance, Risk, PR, Edible, LOI, SMB, CVS, Safeway, Oil, Providence, CO, Cosmetic industry, Pharmaceutical industry, Public relations, CBD, Costco

North Providence, RI, and Golden, CO, June 02, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc.(OTCQB: RLBD) announced today that it has signed a letter of intent (LOI) to acquire substantially all the assets of Boulder Botanicals & Biosciences Laboratories, Inc. (Boulder Botanical), a manufacturer of white-label and private-label CBD and non-CBD products.

Key Points: 
  • North Providence, RI, and Golden, CO, June 02, 2022 (GLOBE NEWSWIRE) -- Real Brands Inc.(OTCQB: RLBD) announced today that it has signed a letter of intent (LOI) to acquire substantially all the assets of Boulder Botanicals & Biosciences Laboratories, Inc. (Boulder Botanical), a manufacturer of white-label and private-label CBD and non-CBD products.
  • Since 2018, Boulder Botanical has designed leading cannabinoid formulations and provided well-recognized, white-label manufacturing services.
  • The Boulder Botanicals transaction will augment Real Brands existing portfolio of branded products and expand its distribution capabilities, explained Thom Kidrin, President & CEO of Real Brands Inc.
  • We are pleased to have the Boulder Botanicals business join the Real Brands family under its seasoned management team, said David Frankens, owner of Frankens Investments.

DGAP-News: Symrise starts successfully into fiscal year 2022

Retrieved on: 
Wednesday, April 27, 2022
Cosmetic industry, Pet food, Travel, Nutrition and Health, Hygiene, Taste, Aladdin (food & beverage containers), Life, Food, EBITDA, CAGR, Group, Aroma compound, Leisure, Cosmetics, Growth, Menthol, Nutrition, Solution, Drink, Symrise, Fine chemical, Perfume, Bottled water, Renewable energy, Coronavirus

Symrise AG made a successful start to the new fiscal year.

Key Points: 
  • Symrise AG made a successful start to the new fiscal year.
  • "At the start of the year, Symrise has seamlessly continued the positive business trajectory of the prior year.
  • Over the medium term, Symrise is targeting an EBITDA margin in the range of 20 to 23 % until the end of fiscal year 2025.
  • Its sales of 3.8 billion in the 2021 fiscal year make Symrise a leading global provider.

DGAP-News: Symrise achieves strong sales and earnings growth with high profitability in fiscal year 2021

Retrieved on: 
Saturday, March 5, 2022
DAX, Oral hygiene, Investment, Life, Federal Executive Boards, Nutrition, Supervisory board, Pet food, Drink, Menthol, Consciousness, Depreciation, Taste, Board of directors, Nutrition and Health, Behavior, Growth, Cosmetic industry, Company, Lanxess, Acquisition, Food, Tax, CEO, EBITDA, CAGR, Odor, Group, Coronavirus, Cosmetics, Symrise, Fine chemical, Animal, Video game, Bottled water, Perfume, Renewable energy

Symrise AG outstandingly capitalized on the economic recovery in 2021 and successfully continued the profitable growth course.

Key Points: 
  • Symrise AG outstandingly capitalized on the economic recovery in 2021 and successfully continued the profitable growth course.
  • Shareholders are to participate in the success of the company with a dividend of 1.02 for the fiscal year 2021.
  • In fiscal year 2021, Symrise increased earnings before interest, taxes, depreciation and amortization (EBITDA) to an outstanding 814 million.
  • The Scent & Care segment increased sales in the fiscal year 2021 by 8.9 % to 1,491 million (2020: 1,369 million).

DGAP-News: Symrise continues accelerated growth course

Retrieved on: 
Tuesday, October 26, 2021
Probiotic, Pet food, Sensient Technologies, Growth, Travel, PETS, Flavor, Food, Oral hygiene, Vanilla, Leisure, Cosmetic industry, Consumer, Menthol, Life, Drink, Symrise, Cosmetics, CEO, CAGR, Odor, Coronavirus, Animal, Perfume, Fine chemical

Further raising of sales target for 2021: organic growth of around 9 % expected

Key Points: 
  • Further raising of sales target for 2021: organic growth of around 9 % expected
    Symrise AG successfully continued its profitable growth course in the third quarter of 2021.
  • We are extremely satisfied with our business development since the beginning of the year and we are continuing our accelerated growth path," said Dr Heinz-Jrgen Bertram, CEO of Symrise AG.
  • Overall, the division achieved strong double-digit organic sales growth in the first nine months and further accelerated growth in the third quarter.
  • Symrise intends to achieve this increase with annual organic growth of 5 to 7 % (CAGR) and complementary strategic acquisitions.